NeueHealth, Inc.
NEUE
$6.82
-$0.03-0.44%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.83% | 5.31% | 18.90% | 28.83% | 24.44% |
| Total Other Revenue | -27.01% | -27.25% | -22.91% | -34.78% | -26.92% |
| Total Revenue | -11.96% | -20.57% | -13.54% | -24.16% | -18.45% |
| Cost of Revenue | -18.28% | -30.19% | -19.32% | -27.52% | -24.31% |
| Gross Profit | 13.84% | 70.48% | 16.94% | -8.54% | 19.27% |
| SG&A Expenses | -27.09% | 0.13% | -32.52% | -0.07% | -16.04% |
| Depreciation & Amortization | -21.99% | -10.51% | -14.89% | -14.84% | -16.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.53% | -23.73% | -23.11% | -21.31% | -22.29% |
| Operating Income | 111.52% | 44.10% | 69.09% | -17.04% | 48.17% |
| Income Before Tax | -120.89% | 29.53% | 95.19% | -21.06% | 112.06% |
| Income Tax Expenses | -83.26% | -142.26% | 182.51% | 79.04% | -47.34% |
| Earnings from Continuing Operations | -125.28% | 32.39% | 94.57% | -23.88% | 110.55% |
| Earnings from Discontinued Operations | 4.61% | 111.31% | 78.84% | 67.61% | 91.46% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 92.41% | -102.27% | 80.35% | 96.15% | -111.48% |
| Net Income | 26.23% | 98.82% | 90.94% | 48.04% | 90.91% |
| EBIT | 111.52% | 44.10% | 69.09% | -17.04% | 48.17% |
| EBITDA | 133.55% | 38.69% | 73.38% | -25.56% | 52.57% |
| EPS Basic | 17.77% | 93.64% | 89.50% | 44.90% | 85.09% |
| Normalized Basic EPS | 93.93% | -114.91% | 77.36% | 59.65% | 31.81% |
| EPS Diluted | 17.77% | 93.64% | 89.50% | 44.90% | 85.09% |
| Normalized Diluted EPS | 93.93% | -114.91% | 77.36% | 59.65% | 31.81% |
| Average Basic Shares Outstanding | 6.08% | 3.42% | 3.82% | 3.65% | 2.34% |
| Average Diluted Shares Outstanding | 6.08% | 3.42% | 3.82% | 3.65% | 2.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |